Clinical Trial

IASO206 in Patients With Relapsed/Refractory Multiple Myeloma

Name: IASO206 in Patients With Relapsed/Refractory Multiple Myeloma — clinical trial record (NCT07322159)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection(In Vivo CAR-T) in Patients with Relapsed/Refractory Multiple Myeloma

Trial Details

NCT Number	NCT07322159
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Relapsed/Refractory Multiple Myeloma (RRMM)
Enrollment	12 participants
Start Date	2026-01-15
Primary Completion	2026-10-15 (estimated)
Study Completion	2028-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-01-07